Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials

Citation:

Almansour SA, Alqudah MAY, Abuhelwa Z, et al. Ther Adv Med Oncol. 2024 Sep 2;16:17588359241275387. PMID: 39229471; PMCID: PMC11369879.